Cargando…
Prostaglandin D(2) as a mediator of lymphopenia and a therapeutic target in COVID-19 disease
A characteristic feature of COVID-19 disease is lymphopenia. Lymphopenia occurs early in the clinical course and is a predictor of disease severity and outcomes. The mechanism of lymphopenia in COVID-19 is uncertain. It has been variously attributed to the release of inflammatory cytokines including...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373045/ https://www.ncbi.nlm.nih.gov/pubmed/32759007 http://dx.doi.org/10.1016/j.mehy.2020.110122 |